Skip to main content

Puillary Responses as a risk and staging biomarker of preclinical Alzheimer's disease


Study Name Puillary Responses as a risk and staging biomarker of preclinical AD
Principal Investigator(s) Eric Granholm, Ph.D. & Mark Bondi, Ph.D.
Required Diagnosis Normal Cognition, Mild Cognitive Impairment (MCI),  Alzheimer's disease (AD)
Age 60-85
Length 1-2 days (~8 hrs); 1-month pupillometry follow up is optional; ask ONLY cognitively NORMAL to come back for MRIs in 1 and 3 years, but no involvement between those times
Lumbar Puncture ​Yes
MRI Yes
Amyloid PET No
Tau PET No
Compensation Unknown
Contact ​clinicaltrialsadrc@health.ucsd.edu